CLOs on the Move

Enzymotec

www.enzymotec.com

 
Enzymotec develops and manufactures nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies. Since its establishment in 1998, the company has enjoyed accelerated growth, generating impressive sales worldwide, by launching a diverse portfolio of innovative products. Our two business segments leverage our lipid-related expertise: Nutrition and Pharma.   Enzymotec's diverse range of products span the entire human life-cycle - from infancy to old age, providing key ingredients for use in infant formula and nutritional supplements, as well as branded medical foods.   Enzymotec's multi-disciplinary team, including scientists, engineers and business development professionals, have an outstanding track-record in turning advanced ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.enzymotec.com
  • 55 Madison Avenue Suite 400
    Morristown, NJ USA 07960
  • Phone: 973.912.9400

Executives

Name Title Contact Details

Similar Companies

Glycomine

There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. 95% of rare diseases have not one single FDA approved treatment. Glycomine develops therapeutics for diseases which have no treatment options.

ISI Interscience

ISI Interscience is a Troy, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Immune Control

Immune Control is a West Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Edifice Health

Edifice Health is a digital health spin-out company from a 10-year Stanford research in human immunology offering a novel metric of inflammatory health.

Aurinia Pharmaceuticals

Aurinia is a global clinical stage biopharmaceutical company focused on developing and commercializing innovative products to treat identifiable patient populations that are suffering from serious diseases with a high unmet medical need. The company is headquartered in Victoria, BC and focuses its development efforts globally.